Literature DB >> 10599680

Four decades of growth hormone therapy for short children: what have we achieved?

H J Guyda1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599680     DOI: 10.1210/jcem.84.12.6189

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  24 in total

Review 1.  Long-term results of growth hormone therapy in Turner syndrome.

Authors:  J H Bramswig
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Which children should receive growth hormone treatment. Cost-benefit analysis is the key.

Authors:  C J Kelnar
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

3.  Growth hormone in growth hormone deficiency.

Authors:  Paul Saenger
Journal:  BMJ       Date:  2002-07-13

Review 4.  Optimising management in Turner syndrome: from infancy to adult transfer.

Authors:  M D C Donaldson; E J Gault; K W Tan; D B Dunger
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

5.  Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry.

Authors:  G Migliaretti; G Aimaretti; A Borraccino; J Bellone; S Vannelli; A Angeli; L Benso; G Bona; F Camanni; C de Sanctis; A Ravaglia; F Cavallo
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

6.  Final height of short subjects of low birth weight with and without growth hormone treatment.

Authors:  S Zucchini; E Cacciari; A Balsamo; A Cicognani; D Tassinari; E Barbieri; S Gualandi
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 7.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

8.  The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.

Authors:  Melissa Westwood; Arfa R Maqsood; Mattea Solomon; Andrew J Whatmore; Julian R E Davis; Robert C Baxter; Evelien F Gevers; Iain C A F Robinson; Peter E Clayton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-27       Impact factor: 4.310

9.  Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Marc Nicolino; Maïté Tauber; Juliane Leger; Sylvie Cabrol; Irène Bastié-Sigeac; Jean-Louis Chaussain; Joël Coste
Journal:  BMJ       Date:  2002-07-13

Review 10.  Growth hormone therapy and quality of life in adults and children.

Authors:  Deborah J Radcliffe; Joseph S Pliskin; J B Silvers; Leona Cuttler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.